A research group has demonstrated that overexpression of Cdc10-dependent transcript 1 (CDT1), a key regulator of DNA ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...

Highlighting 10 innovative late-stage BioPharma drugs with the potential to reshape treatment paradigms and industry dynamics ...

Five years ago this month, in November 2020, medical history was made at Richmond Pharmacology when a patient received the ...

Are you preparing for UPSC CSE Prelims 2026? Check your progress and revise your topics through this quiz on Science and ...

New research breaks down how scientists use CRISPR technology to lower cholesterol. The cholesterol-lowering effects could be permanent.

Five years ago this month, in November 2020, medical history was made at London-based contract research organisation, Richmond Pharmacology, when a patient received the first CRISPR therapy delivered ...

A new fluorescent sensor is giving scientists an unprecedented view of how cells respond to DNA damage, capturing the repair process as it unfolds in real time. The tool, developed at Utrecht ...

Hosts David and Gina explore how scientists over the centuries unlocked the ability to edit our genes ...

As the global population ages and the disease burden climbs ever higher, more patients than ever before could benefit from cell and gene therapy (CGT) treatments. When the CRISPR-Cas9 technology was ...